In8bio, Inc (INAB) Live Share Price, Invest From India

In8bio, Inc Stock Performance

as on April 3, 2026 at 6:57 am IST

Day's Low
Day's High
$1.35
Day's Price Range
$1.46
$1.43
5.59%
Downside
2.10%
Upside
52 Week's Low
52 Week's High
$1.17
52-Week Price Range
$5.82
$1.43
18.18%
Downside
306.78%
Upside

In8bio, Inc share price movements today

Previous Close: $1.40
Open: $1.37
Volume: 140.4K
Day's Low - High: $1.35 - $1.46
52 Week Low - High: $1.17 - $5.82

In8bio, Inc Historical Returns

1 Month Return: -16.28 %
3 Month Return: -41.46 %
1 Year Return: -70.22 %
3 Year Return: -96.36 %
5 Year Return: 0 %

In8bio, Inc Stock Fundamentals & Key Indicators

Check In8bio, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.8M

EPS (TTM)

-2.4967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-18.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-92.49%

In8bio, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of In8bio, Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
In8bio, Inc	BUY	$13.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.6B	124.84%	141.09	8.45%
Beone Medicines Ltd	NA	$35.4B	NA	124.87	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$113.6B	105.93%	29.16	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$82.2B	60.41%	18.72	31.41%

Stock Returns calculator for In8bio, Inc Stock including INR - Dollar returns

The In8bio, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

In8bio, Inc investment value today

Current value as on today

₹32,190

Returns

-₹67,810

(-67.81%)

Returns from In8bio, Inc Stock

-₹70,455 (-70.45%)

Dollar Impact

₹2,645 (+2.64%)

Analyst Recommendation on In8bio, Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for In8bio, Inc. Average target price of $6.25

In8bio, Inc Share Price Target

Get share price movements and forecasts by analysts on In8bio, Inc.

What analysts predicted

77.12%UPSIDE

Target Price

$6.25

Current Price

$1.43

Analyzed by

10 Analysts

Target

$6.25

In8bio, Inc target price $6.25, a slight upside of 77.12% compared to current price of $1.43. According to 10 analysts rating.

In8bio, Inc Stock’s Investor Sentiment and Interest

Search interest for In8bio, Inc Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 4, 2026 to April 3, 2026

Change:32% versus previous 30 day period

In8bio, Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	3	-	-	-	2	-	-	-	-
Gross Profit	0	3	0	0	0	0	0	0	-	-1
Operating Income	-7	-7	-8	-8	-7	-6	-5	-5	-3	-5
EBITDA	-6	-7	-8	-8	-5	-5	-4	-4	-3	-4
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-8	-8	-7	-6	-5	-5	-3	-4
Income Tax Expense	0	-7	0	-	-	-	-	-	-	-
Net Income	-7	-7	-8	-8	-7	-6	-5	-5	-3	-4
Net Profit Margin	0.00%	-202.72%	0.00%	0.00%	0.00%	-243.86%	0.00%	0.00%	0.00%	0.00%

In8bio, Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-1	-2	-2	-2
Operating Income	-2	-5	-8	-14	-28	-30	-30	-19
EBITDA	-1	-5	-8	-13	-27	-27	-26	-17
Interest Expense	0	-	-	0	1	-	-	-
Depreciation	0	0	0	0	1	2	2	2
Income Before Tax	-2	-5	-8	-14	-28	-30	-30	-19
Income Tax Expense	0	0	0	0	-1	-32	-	-
Net Income	-2	-5	-8	-14	-27	-30	-30	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

In8bio, Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-7	-8	-8	-7	-6	-5	-5	-3	-4
Operating Cash Flow	-4	-7	-6	-6	-4	-3	-3	-3	-2
Investing Cash Flow	0	0	0	0	0	0	-	-	-
Financing Cash Flow	13	0	3	0	11	3	5	0	18
Change in Cash	8	-8	-2	-6	7	0	1	-2	16

In8bio, Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-8	-14	-28	-30	-30	-19
Operating Cash Flow	-4	-7	-13	-24	-23	-24	-12
Investing Cash Flow	0	0	0	-3	0	0	-
Financing Cash Flow	0	24	32	8	27	14	28
Change in Cash	-4	17	19	-18	3	-10	15

Global Institutional Holdings in In8bio, Inc

Funds	Holdings
AIGH Capital Management, LLC	3.3%
Franklin Resources Inc	1.94%
Stonepine Capital Management Llc	1.69%
Two Sigma Advisers, LLC	0.37%
Northwestern Mutual Wealth Management Co	0.03%

See all

Insights on In8bio, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.8% return, outperforming this stock by 95.0%
NO EFFECT
Against Peers
In the last 3 years, In8bio, Inc has experienced a drawdown of -96.4%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 88.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, INAB stock has moved down by -41.5%

About In8bio, Inc

in8bio, inc. (“in8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta t cells. we are developing a broad portfolio of programs and are the first company to advance genetically modified gamma-delta t cells into the clinic.

Organisation	In8bio, Inc
Headquarters	350 5th Avenue, New York, NY, United States, 10118
Industry	Health Technology
CEO	Mr. Tai-Wei Ho
E-voting on shares	Click here to vote

Key Management of In8bio, Inc

Name	Title
Mr. Tai-Wei Ho	Co-Founder, CEO & Director
Dr. Kate Rochlin Ph.D.	President & COO
Dr. Lawrence S. Lamb Ph.D.	Executive VP, Co-Founder & Chief Scientific Officer

FAQs

What is In8bio, Inc share price today?

In8bio, Inc share price today is $1.43 as on April 3, 2026 at 1:27 am IST at the close of the market. In8bio, Inc share today touched a day high of $1.46 and a low of $1.35.

What is the 52 week high and 52 week low for In8bio, Inc share?

In8bio, Inc share touched a 52 week high of $5.82 on April 24, 2025 and a 52 week low of $1.17 on December 19, 2025. In8bio, Inc stock price today i.e. April 3, 2026 at 1:27 am IST is closed at $1.43,which is 75.42% down from its 52 week high and 22.22% up from its 52 week low.

What is In8bio, Inc's market capitalisation today?

In8bio, Inc market capitalisation is $0.00T as on April 3, 2026 at 1:27 am IST.

How to invest in In8bio, Inc Stock (INAB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for In8bio, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in In8bio, Inc Shares that will get you 1.0490 shares as per In8bio, Inc share price of $1.43 per share as on April 3, 2026 at 1:27 am IST.

What is the minimum amount required to buy In8bio, Inc Stock (INAB) from India?

Indian investors can start investing in In8bio, Inc (INAB) shares with as little as ₹93.116 or $1 (as of April 3, 2026 at 5:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹931.16 in In8bio, Inc stock (as per the Rupee-Dollar exchange rate as on April 3, 2026 at 5:41 pm IST). Based on In8bio, Inc share’s latest price of $1.43 as on April 3, 2026 at 1:27 am IST, you will get 6.9930 shares of In8bio, Inc. Learn more about fractional shares .